Skip to Main Content

Paper Details

Comparative Reductions in Investigator-Reported and Adjudicated Ischemic Events in REDUCE-IT.
J Am Coll Cardiol
22
2021
AMR101, CEC, CV death, Cardiovascular Disease, EPA, Hypertriglyceridemic, IPE, Icosapent Ethyl, Ischemic Events, MI, Patients, REDUCE, cardiovascular [CV] death, icosapent ethyl, myocardial infarction, patients, statin, stroke, triglycerides, unstable angina
Author NameAffiliation
Prakriti GabaBrigham and Women's Hospital, Harvard Medical School
Deepak L BhattBrigham and Women's Hospital, Harvard Medical School
Robert P GiuglianoBrigham and Women's Hospital, Harvard Medical School
Jean-Claude TardifMontreal Heart Institute, Universite de Montreal
Christie M BallantyneBaylor College of Medicine, and the Center for Cardiovascular Disease Prevention
Christie M BallantyneBaylor College of Medicine, and the Center for Cardiovascular Disease Prevention
Duane S PintoBeth Israel Deaconess Medical Center, Harvard Medical School
Matthew J BudoffHarbor university of california los angeles Medical Center
  • 1 - 8

Datasets

Release 1.2